Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 36Recruiting 15Terminated 9Withdrawn 5Unknown 4Active not recruiting 3Available 2Not yet recruiting 1No longer available 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Breast Neoplasms 478Neoplasms 329Colorectal Neoplasms 234Carcinoma, Non-Small-Cell Lung 233Lung Neoplasms 203Prostatic Neoplasms 180Carcinoma, Hepatocellular 175Stomach Neoplasms 140Pancreatic Neoplasms 122Leukemia, Myeloid, Acute 112Uterine Cervical Neoplasms 107Rectal Neoplasms 104Multiple Myeloma 91Squamous Cell Carcinoma of Head and Neck 85Recurrence 83Neoplasm Metastasis 79Head and Neck Neoplasms 79Ovarian Neoplasms 73Brain Neoplasms 70Colonic Neoplasms 69Triple Negative Breast Neoplasms 66Esophageal Neoplasms 66Glioblastoma 65Endometrial Neoplasms 58Precursor Cell Lymphoblastic Leukemia-Lymphoma 56Motor Activity 56Small Cell Lung Carcinoma 54Disease 53Hematologic Neoplasms 51Glioma 47

Interventions

fludarabine 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × OTHER × Neuroectodermal Tumors, Primitive × Clear all
NCT07390539 2026-02-05

B7-H3.CD28Z.CART in CNS Neoplasms

Dana-Farber Cancer Institute

Phase 1 Not yet recruiting
70 enrolled
CNS

Brain Neoplasms, Ependymoma, Medulloblastoma, Meningeal Neoplasms, Pinealoma, Central Nervous System Neoplasms, Neuroectodermal Tumors, Primitive, Rhabdoid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡